S. 3176 · 114th Congress
STAAR Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 114th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
BrownSponsorNo cosponsors.
Strategies to Address Antibiotic Resistance Act or the STAAR Act
What it does: CRS summary · Introduced in Senate · Jul 13, 2016
Strategies to Address Antibiotic Resistance Act or the STAAR Act
This bill amends the Public Health Service Act to revise provisions regarding the Antimicrobial Resistance Task Force.
The Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria must provide advice, information, and recommendations to the Department of Health and Human Services.
The Centers for Disease Control and Prevention (CDC) must carry out activities to collect data on antibiotic resistance, including assessing conditions and outcomes related to antibacterial resistance and working with others to obtain human antibiotic drug consumption data.
The CDC must establish Antibiotic Resistance Surveillance and Laboratory Network sites, including to monitor antibiotic-resistant bacteria, describe and respond to outbreaks, and evaluate resistance testing methods.
The National Institute of Allergy and Infectious Diseases must maintain: (1) a Clinical Trials Network on Antibacterial Resistance, and (2) a leadership group to advance a clinical research agenda to address antibacterial resistance.
The CDC must work with state and local health departments to support efforts by groups of health care facilities to prevent the spread of antibiotic-resistant bacteria.
The CDC and the epicenters participating in the Prevention Epicenters Program must work with others to: (1) evaluate prevention programs and interventions to limit infections in health care facilities, and (2) facilitate research on the prevention and control of resistant organisms. The CDC must use research from the epicenters to create and disseminate educational materials for use in health care facilities.Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: STAAR Act
Also known as: Strategies to Address Antibiotic Resistance Act
Latest action (Jul 13, 2016): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Policy area: Health · Origin: Senate · Introduced: Jul 13, 2016
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.